Skip to content

His Pacing Feasibility and Cardiac Electrical Activation

His Pacing in Patients Without Need for Cardiac Resynchronization - Clinical Feasibility and Cardiac Electrical Activation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04739553
Enrollment
25
Registered
2021-02-04
Start date
2021-02-15
Completion date
2024-01-31
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AV Block, Heart Failure, Pacing-Induced Cardiomyopathy

Brief summary

This study will examine the clinical feasibility of His pacing in patients with expected high demand for ventricular pacing and no established indication for cardiac resynchronization therapy. Secondarily, examine differences in electrical and mechanical cardiac activation between traditional pacing and His pacing.

Detailed description

After being informed about the study and potential risks, all eligible patients giving written consent will be included. The study is a clinical single-center interventional study. The patients (n = 25) need to have an expected high demand for ventricular pacing and no established class I indication for cardiac resynchronization therapy. They will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port. Postoperatively, the baseline examinations will include: transthoracic echocardiography, 12-lead ECG with a 3D photography of the chest wall to document ECG electrode location, and a contrast-enhanced cardiac CT scan. The echocardiography and ECG will be performed during traditional right ventricular pacing only and His pacing only. His pacing will be used as the permanent programming of choice if feasible during follow up. The CT scan is used for documenting the final positions of the pacing leads and to create a patient-specific 3D model of the cardiac electrical activation using a software which enables merging of a CT scan and ECG and a CT chest photography. During follow up (1-3 and 12 months), transthoracic echocardiography, 12-lead ECG and 3D chest photography are repeated for assessment of mechanical and electrical function during pacing. The performance of all implanted pacing lead will be evaluated at each follow up visit.

Interventions

DEVICEHis Pacing

The patients will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port.

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Permanent pacemaker indication with expected high demand of right ventricular pacing (\>40%) and left ventricular ejection fraction \>40%.

Exclusion criteria

* No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines) * Hemodynamically unstable patients * Severely reduced kidney function * Former serious adverse reactions to contrast media * Pregnant or lactating * Severe psychiatric disorder which can compromise compliance with protocol

Design outcomes

Primary

MeasureTime frameDescription
Rate of chronic His pacing successEvaluated at 1 year follow upChronic His capture with clinically acceptable pacing threshold (\<=3.5V)

Secondary

MeasureTime frameDescription
Rate of perioperative His pacing successThe implant procedure duration i.e. incision to skin closurePerioperative his capture with clinically acceptable pacing threshold (\<=3.5V)
QRS duration (ms)Implantation to 1 year follow upComparing His pacing and RV pacing
Changes in left ventricular echocardiographic two-dimensional strain dyssynchrony parametersImplant to 1 year follow upComparing left ventricular mechanical dyssynchrony during His pacing and RV pacing using echocardiographic two-dimensional longitudinal strain
Changes in regional right and left ventricular electrical activation delayImplant to 1 year follow upComparing electrical activation pattern during His pacing and RV pacing using non-invasive electroanatomical mapping. This is achieved using software that merges data from a 12-lead electrocardiogram (ECG), chest wall three-dimensional picture of ECG lead positions, and a cardiac computed tomography scan.

Contacts

Primary ContactAnna M Thøgersen, MD DMSc
anmat@rn.dk+4597664427
Backup ContactJacob M Larsen, MD PhD
jaml@rn.dk+4597664456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026